Bill Detail
H.R. 5343
Congress: 119
Title
Ensuring Patient Access to Critical Breakthrough Products Act
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Blake Moore [R-UT-1]
Status
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Status as of Jun 29, 4:37 PM · synced 4h ago
Introduced
2025-09-15
Data source mode: cache
Bill Engagement
Ensuring Patient Access to Critical Breakthrough Products Act
Sponsor
Rep. Blake Moore [R-UT-1]R
Status
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Cosponsors
26D · 25R
Bipartisan
LDA engagement
9 orgs · 9 filings
Top: American Medical Association
Introduced
2025-09-15
Lobbyists on the case
9 orgs · 71 lobbyists · 9 filings mention H.R. 5343 (Ensuring Patient Access to Critical Breakthrough Products Act) in LDA disclosures.
Top orgs filing
- American Medical Association1 filing · 23 lobs
- Johnson & Johnson Services, Inc.1 filing · 16 lobs
- Alzheimer's Association1 filing · 8 lobs
- Crossroads Strategies, LLC1 filing · 8 lobs
- Advanced Medical Technology Assn1 filing · 6 lobs
- Avenue Solutions1 filing · 3 lobs
Lobbyists on this bill
- Jane Adams2026 Q1
- Todd Askew2025 Q3
- Brett Baker2026 Q1The Nickles Group, LLC · U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Direc…
- Elizabeth Barnett2026 Q1
- Jamal Bowleg2025 Q3
- Leif Brierley2026 Q1
- Lindsey Brill2025 Q3
- Larry Camm2026 Q1
+ 63 more